Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).
about
Recommendations for prevention and therapy of person's exposed to B virus (Cercopithecine herpesvirus 1)HIV associated thrombotic microangiopathy.Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades.Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy.Case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy.EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult.Antiviral selection in the management of acute retinal necrosis.Pathogenesis of anemia during human immunodeficiency virus infection.Valacyclovir in the treatment of acute retinal necrosis.Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster.Valacyclovir for the treatment of genital herpes.Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.Beta-herpesvirus challenges in the transplant recipient.Thrombotic microangiopathy in the HIV-2-infected macaque.Genital herpes: antiviral therapy for symptom relief and prevention of transmission.Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.Critical care perspective on immunotherapy in lung transplantation.Novel approaches in fighting herpes simplex virus infectionsFamciclovir: a focus on efficacy and safety.Predictors of HIV-associated nephropathy.A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.Famciclovir and development of thrombotic thrombocytopenic purpura.European guideline for the management of genital herpes, 2010.
P2860
Q23914574-B34DD7D8-B390-46D8-AA0E-8A5F627CDDE4Q33344468-108E9B70-5D93-430C-813D-0AB6F0B2250DQ33358266-03B7B2D6-4026-4AA2-B738-35730BAB0A54Q33364650-2B23FFD9-5DEE-426E-90FC-354850D01D5DQ33400326-85EFFB6D-6554-464C-A299-9BE9BF9D86C3Q33443601-94E91E82-1D12-4AD6-996F-663193536B98Q33644146-D594D056-6EBF-447F-ABB4-3E0B86A100EEQ34250579-9C46CE21-D6AE-44B7-B43B-D879AC05CACEQ34403015-DC49B630-E14D-46C7-A976-1F216E599523Q34551831-7492B657-8C92-4FA5-99F8-C5AFFA37E14AQ34568338-BB414678-F57A-4CFA-8189-76B298AA33F0Q34918273-20C20458-1140-4891-ABB2-7705721C3E20Q34918418-9D737DC1-E8F6-4590-B57D-D8B343D8DBFCQ35787796-0EBA8A06-3015-420B-A428-CE1ADCB266F9Q36429709-0AC1966F-B1BA-45CA-BB06-6B9DB6BEAB7CQ36632255-CBA658CD-EDCF-48C7-A957-A390F4A5A13AQ36649380-528136C2-4A81-4CB5-A557-002619851F33Q37316071-D55C0601-ECD7-4268-8F53-F5571BF8EDDAQ37739461-43A9A582-3233-4893-8E59-0C4BC509B0B0Q38198151-5B75A02B-5255-4E37-9CFE-09F538E61631Q43567469-02643725-48A0-4C20-92DA-75DEE2CB9E64Q43891817-F084A5CC-D47F-4322-ACC0-5DD4B66BF330Q46889866-2795616E-198B-482F-898A-E1E3691BA7D6Q50525827-DA26A943-DBD8-412D-90D9-CF435C71D5C1
P2860
Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@ast
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@en
type
label
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@ast
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@en
prefLabel
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@ast
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@en
P2093
P1433
P1476
Manifestations resembling thro ...... prophylaxis trial (ACTG 204).
@en
P2093
P304
P356
10.1097/00005792-199709000-00004
P407
P577
1997-09-01T00:00:00Z